⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NSRX News
Nasus Pharma Ltd.
Nasus Pharma to Participate in Upcoming Investor Conferences
globenewswire.com
NSRX
RedChip's Biotech Virtual Investor Conference Replays Now Available
accessnewswire.com
INAB
DMAC
NSRX
CLDI
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
accessnewswire.com
INAB
DMAC
NSRX
CNTB
CLDI
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
globenewswire.com
NSRX
BriefCast Publishes Transcript: Nasus Pharma NS002 Phase 2 Positive Topline Results Webinar Transcript
globenewswire.com
NSRX
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold
globenewswire.com
NSRX
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
globenewswire.com
JUNS
DYAI
PHIO
CVKD
TNXP
MTVA
XAIR
AEMD
NSRX
ICU
JAGX
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
globenewswire.com
NSRX
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
globenewswire.com
NSRX
Nasus Pharma to Participate in Upcoming Investor Conferences
globenewswire.com
NSRX